XELJANZ XR 22 mg/1 (Tofacitinib TABLET, FILM COATED, EXTENDED RELEASE) 22 mg/1

XELJANZ XR 22 mg is an extended-release tablet containing tofacitinib, used for managing specific inflammatory conditions. This medication is designed for oral administration and is available in a 30-tablet bottle.

Strength

22 mg/1

Pack Size

30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0069-0502-30)

Manufacturer / TM Owner

Pfizer Laboratories Div Pfizer Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

XELJANZ XR 22 mg is primarily used for the treatment of inflammatory conditions such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. Tofacitinib, the active ingredient, works by modulating the immune response to reduce inflammation and alleviate symptoms. Patients often wonder, 'What is XELJANZ XR used for?' This medication is typically prescribed when other treatments have not been effective or are not suitable.

Side Effects

Common effects of XELJANZ XR 22 mg may include upper respiratory tract infections, headache, and nausea. Some users might experience increased blood pressure or changes in cholesterol levels. It's important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

Precautions & Warnings

XELJANZ XR 22 mg should be handled with care, especially for individuals with a history of infections, liver problems, or blood disorders. Regular blood tests may be recommended to monitor for potential side effects. Always follow the guidance of a healthcare professional regarding the use of this medication.

Avoid Interactions

XELJANZ XR 22 mg may interact with certain medications, including those that affect the immune system or blood clotting. It's advisable to avoid alcohol while taking this medication, as it can increase the risk of side effects. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

References

Frequently Asked Questions

XELJANZ XR 22 mg is used to manage inflammatory conditions such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis.

XELJANZ XR 22 mg is taken orally, typically once daily, as prescribed by a healthcare provider.

Common side effects may include upper respiratory tract infections, headache, and nausea.

XELJANZ XR may interact with certain medications, so it's important to consult a healthcare provider before combining it with other treatments.

Long-term use of XELJANZ XR should be monitored by a healthcare provider to assess its safety and effectiveness.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.